Bristol Myers Squibb (BMY)

[chmcnfunds]

From The Fly:

"Dems to force drug price votes in fight over 'repeal resolution,' Politico says Senate Democrats plan to introduce a number of amendments to the upcoming budget resolution -- designed to facilitate a repeal of Obamacare -- including measures targeting drug pricing, reports Politico, citing sources. Al Franken and Amy Klobuchar are among Senators planning to introduce such amendments, spokespeople told the publication. The pricing measures could include a vote on drug importation, which Politico argues "stands a chance at making it through the upper chamber" given the concept's popularity among some Republicans. One lobbyist told the publication that Democrats are "eager" to continue to pressure Donald Trump on drug pricing. Publicly traded companies in the space include AstraZeneca (AZN), Bristol-Myers (BMY), Eli Lilly (LLY), GlaxoSmithKline (GSK), Johnson & Johnson (JNJ), Merck (MRK), Novartis (NVS), Pfizer (PFE), Mylan (MYL), Celgene (CELG), AbbVie (ABBV), Amgen (AMGN), Valeant (VRX) and Allergan (AGN). Reference Link"

Read more at:
http://thefly.com/landingPageNews.php?id=2483929

BMY